CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice Abstract. The COVID-19 pandemic represents a major public health problem. A fraction of the population is at increased risk of developing complications of this disease, in particular older subjects as well as diabetic, obese and hypertensive patients. With regard to patients with high blood pressure, the existence of an increased risk remains to be confirmed in large controlled trials. So far the findings regarding this question are reassuring, whether these patients are treated or not. There seems to be no reason to worry when using blockers of the renin-angiotensin system. The observations available to date suggest that COVID-19 vaccine can be administered safely to hypertensive patients. In conclusion, there is no reason to implement changes in the care of hypertensive patients due to the pandemic.
Zusammenfassung.
Keywords: COVID-19; COVID-19 vaccine; antihypertensive therapy; blockers of the renin-angiotensin system; bloqueurs du système rénine-angiotensine; facteurs de risque; hypertension; hypertension artérielle; risk factors; traitement antihypertenseur; vaccination Covid-19.